Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short- and long-acting benzodiazepines.

H P Willumeit, H Ott, W Neubert
{"title":"Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short- and long-acting benzodiazepines.","authors":"H P Willumeit,&nbsp;H Ott,&nbsp;W Neubert","doi":"10.1007/978-3-642-69659-6_16","DOIUrl":null,"url":null,"abstract":"<p><strong>Subjects and methods: </strong>54 healthy volunteers took part in 3 placebo controlled double-blind trials designed partly as crossover, partly as parallel group studies. The long-acting (elimination half-life greater than 24 h) test drugs diazepam (DIA 5; 10 mg) and flurazepam (FLU 30 mg) were compared to the short-acting drugs (elimination half-life less than 12 h) lormetazepam (LOR 1.5; 2 mg) and mepindolol sulfate (MEP 10 mg; betablocker) following acute or subchronic application. Alcohol (ALC; 0.4-0.8 per mill blood ALC concentration) was used as a compound interfering with the test drugs. Measurements with the driving simulator TS2 were taken at different times between 1 h and 15 h p.a.</p><p><strong>Results: </strong>Subchronic use of FLU causes significant impairment of driving performance the next morning in contrast to LOR which even increases the driving ability. The ALC potentiating effect of LOR is larger than that of DIA after acute intake. MEP acts like placebo but reduces blood pressure and heart rate. Interaction of LOR and ALC in the evening does not result in a prolonged hangover effect which could disturb driving performance the next morning.</p><p><strong>Discussion: </strong>Short-acting benzodiazepines without active metabolites have a profound advantage over those with long-acting accumulating characteristics in respect to matutinal car driving ability, if those drugs are used as nighttime hypnotics. These results highlight the necessity of screening hypnotic and tranquilizing drugs concerning their influence on car driving performance at different times after intake and under conditions of interactions with psychotropic drugs, especially alcohol. In view of future methodological requirements a revised model of driving simulation is presented. It is based on a coherent description of the system \"driver-vehicle environment\" at the level of visual conditions, vehicle behaviour and driver performance. Preliminary data are shown.</p>","PeriodicalId":77887,"journal":{"name":"Psychopharmacology. Supplementum","volume":"1 ","pages":"182-92"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-642-69659-6_16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

Abstract

Subjects and methods: 54 healthy volunteers took part in 3 placebo controlled double-blind trials designed partly as crossover, partly as parallel group studies. The long-acting (elimination half-life greater than 24 h) test drugs diazepam (DIA 5; 10 mg) and flurazepam (FLU 30 mg) were compared to the short-acting drugs (elimination half-life less than 12 h) lormetazepam (LOR 1.5; 2 mg) and mepindolol sulfate (MEP 10 mg; betablocker) following acute or subchronic application. Alcohol (ALC; 0.4-0.8 per mill blood ALC concentration) was used as a compound interfering with the test drugs. Measurements with the driving simulator TS2 were taken at different times between 1 h and 15 h p.a.

Results: Subchronic use of FLU causes significant impairment of driving performance the next morning in contrast to LOR which even increases the driving ability. The ALC potentiating effect of LOR is larger than that of DIA after acute intake. MEP acts like placebo but reduces blood pressure and heart rate. Interaction of LOR and ALC in the evening does not result in a prolonged hangover effect which could disturb driving performance the next morning.

Discussion: Short-acting benzodiazepines without active metabolites have a profound advantage over those with long-acting accumulating characteristics in respect to matutinal car driving ability, if those drugs are used as nighttime hypnotics. These results highlight the necessity of screening hypnotic and tranquilizing drugs concerning their influence on car driving performance at different times after intake and under conditions of interactions with psychotropic drugs, especially alcohol. In view of future methodological requirements a revised model of driving simulation is presented. It is based on a coherent description of the system "driver-vehicle environment" at the level of visual conditions, vehicle behaviour and driver performance. Preliminary data are shown.

模拟汽车驾驶是测定短效和长效苯二氮卓类药物残留效应和酒精相互作用的有用技术。
受试者和方法:54名健康志愿者参加了3项安慰剂对照双盲试验,部分设计为交叉组研究,部分设计为平行组研究。长效(消除半衰期大于24 h)试验药物地西泮(DIA 5;10 mg)和氟西泮(FLU 30 mg)与短效药物(消除半衰期小于12 h)氯美西泮(LOR 1.5;2毫克)和硫酸美品多洛尔(MEP 10毫克;β受体阻滞剂)急性或亚慢性应用后。酒精(酒精度;0.4-0.8 / ml血ALC浓度)作为干扰试验药物的化合物。使用驾驶模拟器TS2在每小时1至15小时的不同时间进行测量。结果:与LOR相比,亚慢性使用FLU会对第二天早上的驾驶性能造成显著损害,甚至会增加驾驶能力。急性摄入后,LOR的ALC增强作用大于DIA。MEP的作用类似安慰剂,但能降低血压和心率。LOR和ALC在晚上的相互作用不会导致长时间的宿醉效应,从而影响第二天早上的驾驶表现。讨论:没有活性代谢物的短效苯二氮卓类药物如果用作夜间催眠药物,在早晨开车能力方面比那些具有长效积累特征的药物具有深刻的优势。这些结果强调了筛选催眠和镇静药物在摄入后不同时间以及与精神药物(特别是酒精)相互作用条件下对汽车驾驶性能的影响的必要性。考虑到未来的方法要求,提出了一种改进的驾驶仿真模型。它基于在视觉条件、车辆行为和驾驶员表现层面上对系统“驾驶员-车辆环境”的连贯描述。初步数据如下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信